hepatitis b therapeutic drug (vaccine, medicine) market size, demand & global opportunity...

Copyright © Research Nester Pvt. Ltd. www.researchnester.com

Global Hepatitis B Therapeutic Drug Market Outlook :

Industry Insights & Opportunity Evaluation,

2015-2021


Research Nester, currently serving clients from 120+ countries

clients across the globe, is a leading service provider for

strategic market research and consulting. We aim to provide

unbiased, unparalleled market insights and industry analysis to

help industries, conglomerates and executives to take wise

decisions for their future marketing strategy, expansion and

investment etc. We believe every business can expand to its new

horizon, provided a right guidance at a right time is available

through strategic minds. Our out of box thinking helps our

clients to take wise decision so as to avoid future uncertainties.

Through our robust, unbiased extensive primary and secondary

research, we help organizations to understand current and

future market trends, thus letting them making a prolonged yet

dynamic financial investment.

Entering New Emerging Markets

Launch & Viability of Product

Competitive Analysis

Industry Analysis


Real Estate

Food & Beverage

FMCG

Industries

Catered

Energy & Power

Healthcare

Information Technology

Semiconductor

ICT


Our Services

Actionable Insight

Data Collection

Business Solution

Research & Analysis

Data Analysis

Primary

Research

Secondary

/Desk

Research

Company

Analysis

Recommendation Competition

Study

Channel

Assessment

Study of

Developme

nts

Market

Assessment

/Estimation

s/Forecast

Future

Share

Target

Market

In-depth Industry Analysis

Our exhaustive research reports are a combination of qualitative and quantitative data and analysis Research conducted using credible database and industry tools and primary insights Unbiased and detailed analysis of financial statistics, competitor’s analysis Market size estimation (by value and volume) and forecasting Detailed mapping on SWOT Analysis, Porters’ Five Force Model Analysis, PESTEL Analysis

Custom Research Services

Tracking the market as per the industry’s movement Conducting interviews to portray real situations and industry’s trends In-depth analysis and information gathering as per client’s requirement Provide 360 degree approach reports to meet client’s specific requirement

We Offer


Sample Research Presentation Look for Your

Requested Research/TOC


Global Hepatitis B Therapeutic Drug Market

Overview

Hepatitis B, a leading cause of human mortalities across

the globe, is a fatal disease which leads to infections in the

liver. A person suffering from Hepatitis B needs proper

and intensive care which is provided through various

therapeutic drugs of Hepatitis B available in the market.

Global hepatitis B therapeutic drug market was valued at

approximately USD 3.2 Billion in 2014 and is anticipated

to foster at a modest compound annual growth rate

(CAGR) of 2.6% over the forecast period i.e. 2015-2021.

Geographically, the market is segmented into North

America, Latin America, Western and Eastern Europe,

Asia-Pacific and Rest of World. Asia-Pacific hepatitis B

therapeutic market is envisioned to behold the fastest

growth in coming 5-6 years.


Global Hepatitis B Therapeutic Drug Market Size

(USD Billion) & Y-O-Y (%) Analysis, 2015-2021

Source: Research Nester

Market Segmentation

By Products

On the basis of products, the global hepatitis B therapeutic

drug market is segmented into:

Baraclude

Pegasys

Tyzeka

3.29

0.00%

5.00%

10.00%

15.00%

20.00%

25.00%

30.00%

35.00%

40.00%

45.00%

50.00%

0

5

10

15

20

25

30

35

40

45

2015e 2016f 2017f 2018f 2019f 2020f 2021f

Market Size Y-O-Y Growth


Baraclude

Hepsera

Others

By Demography

Global hepatitis B therapeutic drug market can be

segmented based on demography

Male

Female

By Types

Based on the patents, the global hepatitis B market is

divided into

Generic Drugs

Branded Drugs

Growth Drivers and challenges

Increasing incidences of Hepatitis B, rising government

and non-government organizations’ initiatives to promote

use of hepatitis drugs are believed to drive the global

hepatitis B therapeutic drug market over the forecast

period.

However, high cost of hepatitis B drugs and complex

regulatory procedures are likely to dampen the growth of

the market in future.


Market Size and Forecast

North America dominates the global hepatitis B

therapeutic drug market in the world. The hepatitis B drug

market in North America is sparked by higher spending of

government on healthcare industry. The U.S. and Canada

are two major markets of hepatitis B drugs in North

America. The U.S. Hepatitis B drug market is likely to get

fostered by increasing immigration of hepatitis B patients

from emerging nations.

Europe is also expected to account for a larger share of the

global hepatitis B therapeutic drug market during the

forecast period. The market is likely to get propelled by

rising incidence of various types of hepatitis in some of the

major countries such as Germany, Spain, Italy, U.K.,

France, and Hungary.

Asia-Pacific hepatitis B therapeutic drug market is

forecasted to have the highest growth rate owing to

increasing healthcare infrastructure in countries such as

India and China. In addition to that, increase in aging

population in japan is further expected to boost the

hepatitis B therapeutic drug market in the region.

Key Players

The global hepatitis B therapeutic drug market includes

some of the top players such as GlaxoSmithKline, Bristol-

Myers Squibb Company, Mitsubishi Tanabe Pharma


Corporation, Johnson & Johnson, F. Hoffmann-La Roche

Ltd., Gilead Sciences Inc., Merck & Co. Inc., Novartis AG,

AbbVie Inc., etc.

Scope and Context

Overview of the Parent Market

Analyst View

Market Size and Growth

North America

Latin America

Western and Eastern Europe

Asia-Pacific

Rest of World

Segmentation

By Products

By Demography

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity


Key Players (respective SWOT Analysis) and their

Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in

current dynamic environment

To know more about this research, visit:

http://www.researchnester.com/reports/global-hepatitis-

b-therapeutic-drug-market-analysis-opportunity-outlook-

2021/57


For More Info/Enquiry, Please Visit us at:

Research Nester Pvt. Ltd. 1820 Avenue M,

Suite #1113 Brooklyn, New York 11230

U.S. (T) +1 646 586 9123

Canada (T) +1 437 889 3230 U.K. (T) +44 203 608 5919

www.researchnester.com, [email protected]

http://www.researchnester.com/

mailto:[email protected]

hepatitis b therapeutic drug (vaccine, medicine) market size, demand & global opportunity...

Health & Medicine